ReviewAddiction & health2025
The Effect of Opioid Use on Esophageal Cancer: A Systematic Review and Meta-analysis.
Review in Addiction & health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is limited research available on the direct effect of opioid use on esophageal cancer. The objective of this systematic review and meta-analysis is to consolidate the results of previous studies and provide an estimate of the pooled relative risk or odds ratio associated with opioid use in relation to the occurrence of esophageal cancer. Methods: The PRISMA guidelines were utilized to establish a framework for conducting this systematic review and meta-analysis. A systematic search was conducted in international and national databases. PubMed, Web of Science, Scopus, and national electronic databases were searched up to February, 2024. The random-effects model was used to report the results at a 95% confidence interval (CI). Stata 11 was used for data analysis. Findings: Out of the 648 retrieved articles, 11 studies remained in the final analysis (one cohort study and ten case-control studies). In all subgroups analyzed based on the type of odds ratios, no significant heterogeneity was observed. The pooled adjusted odds ratio of opium on esophageal cancer was 1.8 (95% CI: 1.24-2.61), and the pooled crude odds ratio of opium on esophageal was 1.82 (95% CI: 1.55-2.14). Conclusion: The results of this systematic review and meta-analysis showed that there is a significant relationship between opium use and esophageal cancer, and opium can be a serious risk factor for esophageal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.